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Case ReportsThus, this complication is not infrequent and might
therefore be a real concern in the future.
The reasons for occurrence of such a complication are
multifactorial. First, the conjunction of a high transvalvular
(systolic) gradient applied to large size prosthesis leads to
an increased retrograde migration force. Second, too
much atrial protrusion of the prosthesis may favor its
retrograde displacement. This could have been the case in
our patient. Third, underexpansion of the prosthesis might
play a major role. This can result from inadequate sizing
(which seemed not to be the case with our patient) rather
than a technical problem (eg, balloon rupture or insufficient
filling volume of the balloon). Fourth, failed bioprosthesis
with no or mild leaflet calcification may also be at risk.
This was the case in our patient and in another reported
on by Bapat and colleagues.3 Finally, the stent shape of
the deployed prosthesis may have a major role. Some
fluoroscopic aspects (eg, rectangular or trapezoidal with
the larger base facing the atrial cavity) are prone to
secondary migration. The rectangular fluoroscopic aspect
was present in the cases reported by Bapat and colleagues3
and in our patient.
In the literature, prosthesis migration occurred 6 days to
3 months after the procedure. Clinical presentation was
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showing excessive atrial protrusion of the valved stent.
Severe mitral dysfunction secondary to retrograde
prosthesis migration after mitral ViV has been successfully
treated by either surgical mitral valve replacement or redo
mitral ViV.1,3
Our report is important because it shows that prosthesis
dislodgment may occur late (>1 year) after ViV. Close
follow-up is mandatory, especially in at-risk patients.
Furthermore, due to a probable high risk of delayed
migration, criteria for proper prosthesis implantation should
be accurately defined in this setting. Our observation with
previous reports may also incite valve manufacturers to
improve the design of the currently available percutaneous
prostheses used for ViV implantation.References
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2014;83:E150-4.Percutaneous closure of paravalvular leak in children after left
ventricular outflow enlargement by the Konno procedure with aortic
valve mechanical prosthesisLilia Oreto, MD,a Fiore Salvatore Iorio, MD,a Giacomo Pongiglione, MD, FACC,b and
Paolo Guccione, MD,a Taormina and Rome, ItalyA clinically significant paravalvular leak (PVL) is a
complication of valve replacement with estimated inci-
dence up to 9% in adults.1 However, the incidence of
PVL in children is not reported and its occurrence aftersurgical enlargement of the left ventricular outflow tract
(LVOT) and the aortic annulus is rarely described. Although
a surgical approach has been considered the preferred treat-
ment, it is burdened by high incidence of recurrent leakages
and significant morbidity and mortality.1,2 During the past
decade a percutaneous approach to PVL has been
increasingly employed in an effort to overcome surgery-
related limitations, to the point that successful results are
reported in up to 90% of treated patients.3,4 However,
transcatheter treatment of PVL in children has been
reported after mitral valve replacement but never after
aortic valve replacement.5 We report the experience of
transcatheter closure of aortic PVL in 2 children after
they underwent the Konno procedure and prosthetic aortic
valve implantation.rdiovascular Surgery c Volume 147, Number 5 e61
FIGURE 1. A, Aortography showing a large paravalvular leak close to the left coronary ostium (white arrow). B, A Tyshak mini balloon (Numed,
Hopkinton, NY) was inflated through the leak. C, A patent ductus arteriosus occluder device was released through the leak. D, A smaller leak (white arrow)
is visible close to the right coronary ostium. E, A 3/PDA5 coil (CookMedical, Bloomington, Ind) was delivered through the leak. F, No residual paravalvular
leak is evident, with only trivial intravalvular regurgitation.
Case ReportsCASE 1
An 8-year-old female patient with left isomerism, double
outlet right ventricle, and normal related great arteries
underwent surgical correction at age 2 years. After 4 years
she underwent the enlargement of LVOTand aortic annulus
by the Konno procedure and aortic valve replacement with a
19-mm St Jude bileaflet prostheses (St Jude Medical Inc, St
Paul, Minn). Over time she developed paravalvular
moderate-to-severe regurgitation, due to 2 distinct PVLs
(Figure 1). Under general anesthesia, she underwent trans-
catheter treatment of both leaks. Retrograde aortography
showed the main leak was close to the left coronary ostium
(Figure 1, A). A 0.014-in guidewire was positioned in the
left ventricle through the major leak and a 10-mm Tyshak
mini balloon (Numed, Hopkinton, NY) was inflated to
assess the size of the communication (Figure 1, B). An
8F-PDA-Amplatzer delivery system (AGAMedical Corpo-
ration, Plymouth, Minn) was positioned in the left ventricle
and a 6/4 Amplatzer duct occluder device (AGA Medical
Corporation) was delivered within the leak and released
after careful inspection of the left coronary artery perfusion
and the unrestrained movement of valve leaflets (Figure 1,
C). The subsequent aortography showed complete closure
of the major leak, whereas a smaller PVL was still visible
on the opposite coronary sinus (Figure 1, D). Complete
closure of this communication was obtained with
detachable 3/PDA5 coil (Cook Medical, Bloomington,e62 The Journal of Thoracic and Cardiovascular SurgInd) (Figure 1, E). The final aortography showed complete
closure of both leaks and persistent trivial intravalvular
regurgitation (Figure 1, F). To date, after 8 years’ follow-
up, no recurrence of paraprosthetic leak has been identified.
CASE 2
A 15-year-old female patient with surgically corrected
partial atrioventricular septal defect developed fibro-
muscular subaortic stenosis with aortic regurgitation and
underwent Konno procedure for surgical enlargement of
LVOT as well as aortic valve replacement with a 25-mm
Carbomedics prosthesis (Sorin Biomedica, Saluggia, Italy).
During follow-up, a moderate-to-severe PVL was detected
and transcatheter closure was performed, using an 8/6 Am-
platzer duct occluder device (AGA Medical Corporation)
(Figure 2). In Figure 2,A, PVL is well visualized on the right
anterior side of the prosthetic annulus. Then, a sizing balloon
was inflated through the leak (Figure 2,B) and theAmplatzer
device was finally released (Figure 2,C). Figure 2,D, shows
that there was no more paravalvular regurgitation on
aortography. Unfortunately, the patient died 5 years later
as a result of traumatic intracranial hemorrhage, although
no recurrent leak had been noted after 4 years’ follow-up.
DISCUSSION
PVL is a rare but potentially severe complication after
Konno aortoventriculoplasty and valve replacement.ery c May 2014
FIGURE 2. A, Right anterior paravalvular leak (white arrow). B, Through the leak a sizing balloon was inflated. C, An Amplatzer device (AGAMedical,
Plymouth, Minn) closing the leak. D, The final aortography with no evident paravalvular leak.
Case ReportsIndications for treatment of PVL include significant left
ventricular volume overload, as occurred in our patients,
and/or significant hemolysis. In case of rapid progression
of leak severity, endocarditis must be considered.
Undoubtedly, in children who already have undergone
multiple surgical approaches, the avoidance of repeat ster-
notomy is preferable. Hence, our experience demonstrates
that percutaneous treatment of PVL must be considered
also in children, after careful evaluation of shape, loca-
tion, and dimension of the leak, and its relationship
with coronary ostia. Conversely, percutaneous therapy is
contraindicated when endocarditis is the etiologic
determinant.
A special consideration can be made for patients who
have undergone aortoventriculoplasty; 2 out of 3 leaks we
described were located on the septal side of the aortic
annulus, which was actually constituted by the surgical
enlargement patch. Therefore, although the suturing
technique may account for partial discontinuity, it should
be noted that the irregularity of the surgically reconstructedThe Journal of Thoracic and Caannulus can act as predisposing factor for partial prosthesis
dehiscence.
CONCLUSIONS
Our experience indicates that transcatheter closure of
PVL after aortic valve replacement is feasible in children
and provides a valid option to surgery, particularly in
patients who have undergone multiple surgical procedures.References
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